IA
STOK icon

IFP Advisors’s Stoke Therapeutics STOK Stock Holding History

IFP Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$164 Hold
5
– – ﹤0.01% 4892
2026
Q1 		$163 Hold
5
– – ﹤0.01% 4653
2025
Q4 		$159 Hold
5
– – ﹤0.01% 4513
2025
Q3 		$118 Buy
+5
New +$86 ﹤0.01% 4516
2025
Q2 		– Hold
0
– – – 4602
2025
Q1 		– Sell
-6
Closed -$66 – 4619
2024
Q4 		$66 Buy
+6
New +$74 ﹤0.01% 4169

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors's STOK Position: Q2 2026 in Review

IFP Advisors held its Stoke Therapeutics (STOK) position steady in Q2 2026 at 5 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #4892.

IFP Advisors first reported a position in STOK in Q4 2024 and has held it in 5 quarters since. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • IFP Advisors held 5 shares of Stoke Therapeutics worth $164 as of Q2 2026.
  • IFP Advisors left its Stoke Therapeutics share count unchanged in Q2 2026.
  • Stoke Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4892 holding.
  • IFP Advisors first reported a position in Stoke Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.